Non-immune risk predictors of cardiac allograft vasculopathy: Results from the U.S. organ procurement and transplantation network - International Journal of Cardiology
Cardiac allograft vasculopathy - Wikipedia
Negative Predictive Value and Prognostic Associations of Rb-82 PET/CT with Myocardial Blood Flow in CAV | JACC: Heart Failure
Cardiac Allograft Vasculopathy: A Donor or Recipient Induced Pathology? | Journal of Cardiovascular Translational Research
Caveolin-3 and Caveolae regulate ventricular repolarization - ScienceDirect
Cardiac Allograft Vasculopathy (CAV) - Weekly Research Conference with Sharon Chih, MD, PhD - YouTube
Retransplant and Medical Therapy for Cardiac Allograft Vasculopathy: International Society for Heart and Lung Transplantation Registry Analysis - American Journal of Transplantation
Cardiac Allograft Vasculopathy 1. What is cardiac ... | GrepMed
Structural Parameters By Cardiac Magnetic Resonance Imaging To Detect Cardiac Allograft Vasculopathy Beyond The First-Year Post-Heart Transplantation: A Prospective Single Center Analysis - Journal of Cardiac Failure
Kaplan–Meier CAV-free Survival by Statin Intensity | Radcliffe Cardiology
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant Recipients - ScienceDirect
Interacting Mechanisms in the Pathogenesis of Cardiac Allograft Vasculopathy | Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiac allograft vasculopathy - Wikipedia
Cardiac Allograft Vasculopathy (CAV) with UCSD - CardioNerds
Sharon Hunt, Author at Cancer Therapy Advisor
Cardiac Allograft Vasculopathy: An Ongoing Challenge in the Care of Heart Transplant Recipients | IntechOpen
Coronary Allograft Vasculopathy: An Unbeatable Foe in Cardiac Transplantation?, October 30, 2020 - YouTube
Allograft Vasculopathy: The Achilles' Heel of Heart Transplantation - ScienceDirect
PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy | Journal of the American College of Cardiology
Sara Ward on X: "CAV is a recognized complication seen post-cardiac transplant and is amongst the top 3 causes of death after transplantation. Great information below regarding CAV prophylaxis for the heart
Coronary cardiac allograft vasculopathy versus native atherosclerosis: difficulties in classification | Virchows Archiv
Patient flow chart. CAV = cardiac allograft vasculopathy | Download Scientific Diagram
Nomenclature for cardiac allograft vasculopathy (CAV) | Download Scientific Diagram
Multiparametric Cardiac Magnetic Resonance Imaging Detects Altered Myocardial Tissue and Function in Heart Transplantation Recipients Monitored for Cardiac Allograft Vasculopathy
Prophylactic use of mTOR inhibitors and other immunosuppressive agents in heart transplant patients | Cellular & Molecular Immunology
Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era - Journal of Cardiac Failure
